SP047ORAL TREATMENT WITH PBI-4547, A NOVEL FIRST-IN-CLASS ANTI-DIABETIC AND ANTI-FIBROTIC COMPOUND, IMPROVES GLOMERULAR FUNCTION AND PREVENTS PODOCYTE INJURY IN THE DIABETIC DB/DB MOUSE MODEL
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.